🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This is a Phase 2, prospective, multicenter, open-label, single-arm study o...
Status
Completed
Location
Szpital Kliniczny Przemienienia Pańskiego UM w Poznaniu, Klinika Chirurgii Ogólnej i Naczyń
Start Date
2019-11-12
Trial ID
NCT04135417
Treatments Being Tested
This is a 52 week, single center, randomized, double-blind, placebo-control...
Status
Recruiting
Location
Hospital for Special Surgery
Start Date
2019-07-29
Trial ID
NCT03844061
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842
This international, multi-centre, double-blind vaccine study is a three-arm...
Status
Completed
Location
MRC/UVRI and LSHTM Uganda Research Unit
Start Date
2020-12-15
Trial ID
NCT04066881
Treatments Being Tested
This study evaluates the use of the Acellular Tissue Engineered Vessel (ATE...
Status
Completed
Location
Jacob Medical Center at UC San Diego
Start Date
2018-09-01
Trial ID
NCT03005418
Treatments Being Tested
The purpose of this experimental therapy is to evaluate the safety and effi...
Status
Unknown
Location
Wroclaw Medical University
Start Date
2016-03-01
Trial ID
NCT03933072
This is an open-label, non-randomized, single-institution, single arm Phase...
Status
Active Not Recruiting
Location
University of Colorado Hospital
Start Date
2020-01-28
Trial ID
NCT04028063
Treatments Being Tested
The goal of this clinical trial is to compare participants with ovarian, fa...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2015-02
Trial ID
NCT02346747
This is an open-label Phase I study, four dose escalation groups, to evalua...
Status
Unknown
Location
Tel Aviv Medical Center
Start Date
2020-09-25
Trial ID
NCT04747574
Treatments Being Tested